Idera Pharmaceuticals, Inc. (IDRA) to Present at the Piper Jaffray Healthcare Conference  
11/26/2012 11:11:58 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), a biotechnology company developing Toll-like receptor targeted product candidates for the treatment of autoimmune diseases and as vaccine adjuvants, today announced that its management will present a company overview at the 24th Annual Piper Jaffray Healthcare Conference in New York, NY. The presentation will take place on Wednesday, November 28, 2012 at 9:00 a.m. ET. A live audio webcast of the presentation will be available in the Investor section of Idera's website: An archived version will also be available on the Company's website after the event for a limited time.